Does myocardial revascularization with multiple arterial grafts improve the prognosis of dialysis patients?

Hiroyuki Tanaka1, Takashi Narisawa, Takanobu Mori

  • 1Department of Thoracic Cardiovascular Surgery, Showa University Fujigaoka Hospital, Yokohama, Japan. h.tanaka@showa-university-fujigaoka.gr.jp

Insights

Multiple arterial grafts in myocardial revascularization show promising short-term outcomes for dialysis patients, potentially improving cardiac death survival rates. However, overall survival was not significantly different due to non-cardiac deaths.

Area of Science:

  • Cardiovascular Surgery
  • Nephrology
  • Oncology

Background:

  • Dialysis patients face increased cardiovascular risks.
  • Myocardial revascularization aims to improve outcomes in this high-risk group.

Purpose of the Study:

  • To evaluate if multiple arterial grafts improve prognosis in dialysis patients undergoing coronary artery bypass grafting.
  • To compare short-term and long-term results of multiple arterial grafts versus single arterial grafts with vein grafts.

Main Methods:

  • Retrospective analysis of 20 dialysis patients undergoing coronary artery bypass grafting.
  • Patients divided into two groups: Group A (≥2 arterial grafts) and Group B (1 internal thoracic artery + vein grafts).
  • Comparison of surgical outcomes, operative risk, and survival rates (overall and cardiac-specific).

Main Results:

  • No significant differences in patient profiles between groups.
  • Group A had a higher mean arterial graft number (2.2 vs. 1.0).
  • No mediastinitis or brain complications; Group A had no operative deaths versus one in Group B.
  • 55-month actuarial survival: Group A (0.53 overall, 0.80 cardiac) vs. Group B (0.42 overall, 0.53 cardiac).
  • Cardiac death survival was better in Group A, but not statistically significant.

Conclusions:

  • Myocardial revascularization with multiple arterial grafts offers good short-term results for dialysis patients.
  • This approach may enhance long-term survival related to cardiac death.
  • Overall survival differences were not significant due to a high rate of non-cardiac mortality in the study cohort.